![](/img/cover-not-exists.png)
Phase II, two-stage study of avelumab in patients with microsatellite stable (MSS), microsatellite instable (MSI) and polymerase epsilon (POLE) mutated recurrent or persistent endometrial cancer
Konstantinopoulos, P.A., Liu, J.F., Barry, W., Krasner, C., Buss, M.K., Birrer, M.J., Farooq, S., Campos, S.M., Stover, E., Schumer, S., Wright, A.A., Dizon, D.S., Luo, W., Penson, R.T., Cannistra, S.Volume:
149
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2018.04.060
Date:
June, 2018
File:
PDF, 263 KB
english, 2018